Effect of Positive Biopsy Core Rate on Low-dose-rate Brachytherapy Outcomes in Intermediate-risk Prostate Cancer.
Kusuhara Y, Fukawa T, Fukumori T, Ueno Y, Daizumoto K, Sasaki Y, Tomida R, Yamamoto Y, Yamaguchi K, Tonoiso C, Kubo A, Kawanaka T, Furutani S, Ikushima H, Kanayama HO, Takahashi M.
Kusuhara Y, et al. Among authors: sasaki y.
Anticancer Res. 2023 Oct;43(10):4627-4635. doi: 10.21873/anticanres.16657.
Anticancer Res. 2023.
PMID: 37772553